Abstract: Methamphetamine (MA) is one of the most addictive psychostimulant drugs with a high potential for abuse. Our previous studies demonstrated that MA administered to pregnant rats increases pain sensitivity and anxiety in their adult offspring and makes them more sensitive to acute administration of the same drug in adulthood. Because individuals can differ considerably in terms of behaviour and physiology, such as rats that do not belong in some characteristics (e.g. anxiety) to average, can be described as low-responders or high-responders, are then more or less sensitive to pain. Therefore, prenatally MA-exposed adult male rats treated in adulthood with a single dose of MA (1 mg/ml/kg) or saline (1 ml/kg) were tested in the present study. We examined the effect of acute MA treatment on: (1) the anxiety in the Elevated plus-maze (EPM) test and memory in EPM re-test; (2) nociception sensitivity in the Plantar test; (3) the correlation between the anxiety, memory and the nociception. Our results demonstrate that: (1) MA has an anxiogenic effect on animals prenatally exposed to the same drug in the EPM; (2) all the differences induced by acute MA treatment disappeared within the time of 48 hours; (3) there was no effect of MA on nociception per se, but MA induced
Introduction
Methamphetamine (MA) is one of the most addictive psychostimulant drug with a high potential for abuse. It is also one of the most frequently used "hard" drug in the Czech Republic (Vavřínková et al., 2001 ) and due to its anorectic effects, it is one of the most commonly abused drug among women, even during pregnancy (Marwick, 2000) . Our previous studies demonstrated that MA administered to pregnant rats increases pain sensitivity in their offspring in adulthood (Yamamotová et al., 2011) . In addition, our recent study (Šlamberová et al., 2015) demonstrated that prenatal MA exposure increases anxiety of adult male rats and makes them more sensitive to acute administration of the same drug in adulthood.
In addition, there are studies showing that administration of MA in adulthood improves cognitive processes (Kornetsky et al., 1959) , does not have any effects on cognition (Fialová et al., 2015) , or impairs the learning abilities of adult male rats (Meredith et al., 2005; Schutová et al., 2009 ). This inconsistency seems to be caused by different dose of the drug, duration of the drug exposure and the type of cognition test used in the studies (Simoes et al., 2007; Belcher et al., 2008) . Our previous study demonstrated that the effect of MA administration in adulthood on cognition is influenced by prenatal MA exposure, which seems to correlate withthe present study was set to examine possible correlations between the effects of MA on pain sensitivity and anxiety. To test anxiety EPM test was chosen as the most appropriate test of anxiety . For pain sensitivity the Plantar test was used as in our previous studies (Yamamotová et al., 2011) .
Moreover, the experiment was expanded for the influence on learning and memory in accordance with the protocol "test/re-test" in the EPM . After exploring the maze during the first testing the rat saves the information that the area is not dangerous, in that part of memory that relates to exploration of potentially dangerous areas, and the rat changes its behaviour during the retest. If the drug disrupts learning process, the pattern of behaviour is changed in comparison with the first test (File, 1993; Bertoglio and Carobrez, 2002; Bertoglio et al., 2005) . Based on our previous results we assume that the influence on the consolidation of the memory trace will be not significant.
Methods
The procedures for animal experimentation in this study were reviewed and approved by the Institutional Animal Care and Use Committee and were in agreement with the Czech Government Requirements under the Policy of Human Care of Laboratory Animals (No. 246/1992) and with subsequent regulations from the Ministry of Agriculture of the Czech Republic.
Animals and prenatal care
Adult female (275-300 g) and male (375-400 g) albino Wistar rats provided by Charles River Laboratories International, Inc., were delivered by AnLab (Prague, the Czech Republic). Animals were housed four per cage by sex and left undisturbed for a week in a temperature-controlled (22-24 °C) colony room with free access to food and water on a 12 h (light):12 h (dark) cycle with lights on at 06:00 h. Eight females were impregnated as described in our previous study (Šlamberová et al., 2005) . On gestational day (GD) 1 the daily injections of MA started and continued until the day of delivery, which usually occurred on GD 22. D-methamphetamine HCl (Sigma Aldrich, the Czech Republic) was diluted in distilled water in concentration of 5 mg/ml and injected subcutaneously (s.c.) in a volume of 1 ml/kg. The dose 5 mg/kg of MA was chosen because it induces similar fetal brain drug concentrations and similar behavioural changes to those found in humans (Acuff-Smith et al., 1996; Rambousek et al., 2014) .
The day of the delivery was indexed as postnatal day (PD) 0. On PD 1, pups were weighed and the number of pups was adjusted to 12 per litter. Whenever possible, the number of male and female pups raised by a dam was equal. On PD 21, pups were weaned and group-housed by sex. Animals were left undisturbed until adulthood. In order to avoid litter effects, only two male rat from each litter was used in the present study (one for each adult injection). The rest of the animals were used in other experiments.
Schedule of the experiment
In total 16 adult male rats (PD 80-90) prenatally exposed to MA were tested in this experiment (n=8 rats/group). All of the animals were handled according to the protocol described in Behavioral Science Protocols (Geyer and Swerdlow, 2007) during three days prior to the EPM tests.
After the three days of handling, animals were tested in the EPM. Forty-five minutes prior to testing, animals were injected with either a challenge dose of MA (1 mg/ml/kg) or saline (1 ml/kg). The dose of MA was chosen based on our previous studies (Šlamberová et al., 2010; Schutová et al., 2013) showing that this dose does not induce stereotypical behaviours. The timing of the drug application was chosen based on the study of Rambousek et al. (2014) demonstrating that the peak of MA level in the brain (not in the blood) occurred between the 45 th and 60 th minute after administration. To see the effect of MA on learning, the EPM experiment was further expanded for the protocol of "test/re-test" as shown in the study of Carobrez and Bertoglio (2005) . In details, forty-eight hours after the EPM test, animals retook the test on the EPM (re-test) but without any drug administration. Directly after the re-test on the EPM animals were examined for nociception sensitivity in the Plantar test (see time-line at Figure 1 ).
Elevated plus-maze (EPM)
The same method was used as in our previous study (Pometlová et al., 2012) , which was a modified protocol of Fernández Espejo (1997). All animals were habituated to the laboratory environment and the experimenter during the 3 days prior to the experiment (Geyer and Swerdlow, 2007) . At the beginning of the test an animal was positioned on the center square of plus maze with the animal's nose pointing toward one of the closed arms (CA). Animal behaviour in the EPM was video-recorded for five minutes. Acquired video records were evaluated using the ODLog program (Macropod Software TM ). Animal behaviour was divided into four categories as follows.
The first category included behaviour related to anxiety. The anxiolytic effect on animal behaviour was described as activities in open arms (OA): the number of entries to the OA and total time spent there. Anxiogenic effect on animal behaviour involved activities in the CA and the center: the number of entries to the CA and total time spent there, the number of protected head-dipping (DIP) and protected stretched attend postures (SAP) (Fernández Espejo, 1997) . DIP was defined as head-dipping below surface of the maze that occurred on the center square, while the body of an animal remained in the CA or central platform. SAP was defined as forward elongation of head and shoulders followed by retraction to initial position. In this study it was recorded when it occurred on the central platform, while the body and all paws of an animal remained in the CA.
The second category described approach-avoidance conflict and also depicted types of behaviour with respect to OA and CA, i.e., positioning of an animal with all four paws in the center of the maze followed by retrieval (meaning moving backwards) to the CA.
The third behavioural category in the EPM was used to describe motor activity. Evaluated activities included the total number of entrances into all arms and sniffing in the center of the EPM (mobile or quiet olfactory exploration of the environment).
The last category included displacement behaviour as a measure of anxiety, i.e., self-grooming, etc. This category was not evaluated because at a dose of 1 mg/kg it did not occur.
Frequency of specific behavioural patterns as well as time spent engaged in specific behaviours were used for statistical analyses.
Plantar test
The same method was used as in our previous study (Yamamotová et al., 2011) . Plantar test (Plantar test; Ugo Basile, Comerio, Italy) was used to measure nociceptive sensitivity. A beam generator, which is controlled by the experimenter under the floor of the Plexiglas box (size 27×17×14 cm) allows to stimulate the sole (planta) of the paw in a freely moving rat. The latency of paw withdrawal from painful heat stimulus was measured for each of the four paws. Latency to withdrawal of the tail was measured as a modified method of the tail-flick test. The stimulation was repeated four times. Each repetition progressed from more distal to more proximal parts of the tail. The inter-stimulus intervals ranged from 1/2 to 1 min in order to let the animals calm down from the preceding stimulus. The maximal intensity was set to 90 and cut-off time was 22 s to prevent tissue damage.
Statistical analyses
A one-way ANOVA (MA vs. saline) with repeated measure (test vs. re-test) was used for statistical analyses of the results of the EPM test and re-test. Bonferroni post-hoc test was used when appropriate. In the Plantar test, the factor treatment (MA vs. saline) comprised the between-subject variable. The within-subject variables (factor pain) consisted of three measured body sites (average withdrawal latency of forelimb, hind limb and the tail).
An association between pain sensitivity and anxiety was analysed using correlation technique. As the data from EPM were not normally distributed Spearman rank order correlation was applied.
Differences were considered significant if p<0.05. All statistical data in this report are presented as [F(N-1, n-N) = xx.xx; p<0.0x], where F = test criterion of ANOVA, N-1 = degrees of freedom of groups, n-N = degrees of freedom of individual subjects, p = probability level.
Results

Elevated plus-maze test
Concerning the anxiogenic/anxiolytic effect, there were no significant differences in the measure of entries and time spent in the OA (anxiolytic effect), nor in the CA (anxiogenic effect) of the EPM apparatus (Table 1) . However, when more detailed analysis was conducted, animals injected with MA displayed decreased DIP [F(1, 14) = 5.58; p<0.01] and increased SAP [F(1, 14) = 6.40; p<0.01] during the EPM test relative to saline controls (Figure 2) .
The approach-avoidance conflict was significantly changed by the MA administration in the EPM test [F(1, 14) = 8.46; p<0.01], thereby that MA administration increase the number of returns to the CA when compared to saline-treated animals in the EPM (Figure 2) .
The motor activity that was evaluated as number of entries to all arms and frequency as well as time spent with sniffing was not significantly affected by MA administration ( Table 1) . 
Elevated plus-maze re-test
As shown in Figure 2 , there were no differences induced by acute MA administration on DIP, SAP and returns to the CA as shown in the EPM test.
Plantar test
The withdrawal latencies on thermal stimulation were measured after the re-test in the EPM. Neither MA nor saline application influenced nociceptive sensitivity (main effect of treatment [F(1, 14) = 2.13; p=0.17]). Pain sensitivity measured on different 
Correlations
From correlation matrices evaluating pain sensitivity in relation to measured parameters from EPM follows that significant results were obtained only for those animals that were formerly treated with MA. More specifically, after application of MA, animals with lower pain threshold on the tail spent more time in OA [r=-0.71 (Figure 4) . No significant correlations were found in animals previously treated with saline.
Discussion
Our results can be presented in three steps. First, the anxiety data from the EPM test and memory in re-test. Second, the results showing changes in nociception tested in the Plantar test. Third, the correlation between the anxiety, memory and the nociception.
First, our data from the EPM test did not show any robust changes induced by application of MA (no effect on entries and time spend in the open/closed arms). However, our detailed analysis based on studies of Fernández Espejo (1997) and Pometlová et al. (2009) suggests rather anxiogenic effect of acute MA administration, such as increased number of SAP as well as number of CA returns. This is in agreement with our recent study showing anxiogenic effect of prenatal and acute MA exposure in different models of anxiety (Šlamberová et al., 2015) . The only disputatious might be our finding showing decreased number of DIP after acute MA administration. Decreased of DIP is by Fernández Espejo (1997) interpreted as anxiolytic behaviour. Based on our results, however, one may offer different interpretation of these data. Note that DIP is defined as headdipping below surface of the maze that occurred on the center square, while the body of an animal remained in the closed arm or central platform. It is possible that increase of such a behaviour means that these animals are more adventurous and are not afraid of heights so much. This is however only our speculation.
In addition to these findings, re-test in the EPM was conducted 48 hours after the first anxiety testing to test learning ability. Shortly we can say that all the differences between acute MA-and saline-treated groups disappeared within the time of 48 hours. Specifically, the effect of acute MA administration decreased with the time between test and re-test in the number of SAP and number of CA returns. In contrast, there was significant decrease of the number of DIP in saline-treated group, but no change in MA-treated group. This confirms ambiguous effect of acute MA, because after 48 hours the animals are both the same. It should be noted the EPM is a model of "state" anxiety that tests unconditioned responses (Belzung and Griebel, 2001 ). There are many factors that may affect the performance of the EPM test, such as strain, sex, age and housing conditions (Borta and Schwarting, 2005) . Influence of acute administration of MA was not manifested, which is in agreement with our previous Morris water maze study . Second, our data show no differences in nociceptive sensitivity between MAand saline-treated groups. Our previous studies (Yamamotová et al., 2004 (Yamamotová et al., , 2011 Hrubá et al., 2010b; Yamamotová and Šlamberová, 2012) consistently showed that prenatal treatment of pregnant mothers with MA has long-term impact on nociception in their offspring. Even in adulthood these animals have decreased pain thresholds contrary to control animals. Although the mechanism underlying the increased pain perception induced by prenatal exposure to MA is not clear at present, during early stages of development prenatal MA may sensitize nociceptive system via up-regulation of the NMDA receptors activity which then cause an increase in the pain perception due to changes in central excitability Chen et al., 2010; Hrubá et al., 2010a; Vrajová et al., 2014) .
After EPM re-test, the groups did not differ in nociceptive sensitivity. Given that both groups were exposed during the prenatal period to MA, there was no reason to assume that they will differ in this respect. From this point of view, we can assume that the observed reaction to pain is specific characteristic of the individual.
Third, it was shown that chronic pain can lead to anxiety and anxiety can enhance pain (Koga et al., 2015) . However, anxiety can exacerbate pain perception when the source of anxiety is related to the pain experience. When the source is related to something else, anxiety may even reduce the reaction to pain (Weisenberg et al., 1984) . Classification of Wistar rats into high and low anxious animals according their behaviour in the EPM showed that despite their different basal levels of trait anxiety, rats did not exhibit different levels of mechanical hypersensitivity (Wilson et al., 2007) . Contrary to these results, an increase of heat pain threshold was observed in high anxious rats compared to normal Wistar rats (Jochum et al., 2007) .
In addition, our results demonstrated that in the re-test, the groups did not differ in the length of stay and frequency of visits in open and closed arms of the EPM. No relationships were further found between measured characteristics in the EPM and nociception. On the other hand, significant correlations were found between anxiety after application of MA and nociceptive sensitivity measured two days later. It can be interpreted as follows; assuming relatively stable patter in nociception, acute dose of MA had a greater anxiolytic effect in individuals more sensitive to pain than in animals less sensitive to pain and the other way around. A similar relationship between nociception and anxiety was observed in rats after administration of N-feruloylserotonin (extracted from Leuzea carthamoides) which has been demonstrated anxiolytic effect (Yamamotová et al., 2007) .
There are several studies showing that anxiety in the EPM induces analgesia of non-opioid type. In mice, 5-min exposure to the EPM induced a mild, though enduring, elevation in tail-flick latencies and pre-treatments with the opiate antagonist naltrexone failed to block EPM-induced antinociception (Lee and Rodgers, 1990) . In rats, the results shown that open EPM-induced antinociception did not display cross-tolerance to morphine and failed to be reversed by naltrexone (Cornelio and Nunes-de-Souza, 2009 ). Therefore, our animals with higher pain thresholds can be considered more anxious/stressed and the effect of MA might be therefore more anxiogenic, unlike less stressed animals, in which MA might be more anxiolytic.
We can summarize the present data the following way: first, MA has an anxiogenic effect on animals prenatally exposed to the same drug in the EPM; second, all the differences induced by acute MA treatment disappeared within the time of 48 hours; third, there was no effect of MA on nociception per se, but MA induced higher anxiety in individuals less sensitive to pain than in animals more sensitive to pain. To conclude, the present study demonstrates unique data showing association between anxiety and nociceptive sensitivity of prenatally MA-exposed rats that is induced by acute drug administration.
